Overview of Dr. Chen
Dr. Linda Chen is a radiation oncologist in Montvale, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. She received her medical degree from Duke University School of Medicine and has been in practice 3 years. She is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 6 doctors at Memorial Sloan Kettering Bergen who specialize in Radiation Oncology. She has more than 30 publications and over 500 citings.
Office
225 Summit Ave
Montvale, NJ 07645
Education & Training
- Johns Hopkins UniversityResidency, Radiation Oncology, 2014 - 2018
- Johns Hopkins UniversityInternship, Internal Medicine, 2013 - 2014
- Duke University School of MedicineClass of 2013
Certifications & Licensure
- NJ State Medical License 2018 - 2025
- NY State Medical License 2018 - 2025
- American Board of Radiology Radiation Oncology
Clinical Trials
- A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) Start of enrollment: 2022 Mar 24
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 11 citationsHypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.Nancy Y Lee, Eric J Sherman, HeiKo Schöder, Rick Wray, Jay O Boyle
Journal of Clinical Oncology. 2024-03-10 - 28 citationsConsensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer.Jung Julie Kang, Yao Yu, Linda Chen, Kaveh Zakeri, Daphna Yael Gelblum
CA. 2023-03-01 - 232 citationsConcurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.Linda Chen, Jacqueline Douglass, Lawrence Kleinberg, Xiaobu Ye, Ariel E. Marciscano
International Journal of Radiation Oncology, Biology, Physics. 2017-12-05
Press Mentions
- Low-Dose Radiation a Possible 'Game Changer' for Treating HPV-Positive Throat CancerAugust 17th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: